Brother Technology: Subsidiary Iodipanol Injection Obtains Drug Registration Certificate.

Brother Technology announced on September 21st that its wholly-owned subsidiary Zhejiang Brother Pharmaceutical Co., Ltd. has obtained the "Drug Registration Certificate" issued by the National Medical Products Administration for Iopamidol Injection. Iopamidol Injection is mainly used for cardiovascular imaging, peripheral artery imaging, venous imaging, coronary artery imaging, cerebral vascular imaging, urinary tract imaging, lumbar/thoracic and cervical spinal cord imaging, joint imaging, and CT enhanced examination. It has the characteristics of low viscosity and good safety. Iopamidol Injection has been included in the national medical insurance category A list and has been included in the seventh batch of national drug centralized procurement catalog.